Statutory Committee decisions
The Statutory Committee of the Royal Pharmaceutical Society of Great Britain met on Monday 23, Tuesday 24, Wednesday 25 and Thursday 26 July 2007, and made the following decisions:
1. Following the inquiry into the case of Ian Anthony McAsey (registration
number 85173) the committee directed the removal of Mr McAsey’s
name from the Register. The committee found proved the allegation that
the authorisation and subsequent receiving of payments of £212
and £336, which he was not entitled to, while working as a locum
pharmacist and the subsequent failure to report or repay the amount,
amounted to misconduct. Under Section 11 of the Pharmacy Act 1954, the
direction to remove Mr McAsey’s name from the Register is not to
take effect until the expiration of a period of three months from the
date on which notice of removal was given or in a case where an appeal
has been brought against the direction, until the appeal is determined
or withdrawn.
2. Following an inquiry into the case of Nathan Simpson (registration number
1077828) the committee resolved to issue Mr Simpson with a reprimand. The committee
found proved the allegation that the creation of a personal website while a
preregistration student in which he used the initials MRPharmS after his surname
when he was not entitled to do so and included directional links to other websites
which contained pornographic material and/or other material that others might
find offensive amounted to misconduct.
3. Following an inquiry into Mohammed Shabir (registration number 87816) the
committee directed the removal of Mr Shabir’s name from the Register.
The committee found proved the allegations that: dispensing or causing to be
dispensed to members of the public medication which had previously been dispensed
to patients in a care home and which had been subsequently returned unused
by the care home to the pharmacy; instructing a dispenser to use such returned
medication from the care home for community patients, telling her that these
people would not understand the significance of the numbers written on the
packaging; failing to ensure (a) that Controlled Drugs were kept in a locked
cabinet, safe or room, (b) the safety and quality of medicines supplied to
patients, (c) that returned medicines were not supplied to patients, (d) that
pharmaceutical waste was segregated from pharmacy stock, and (e) that batch
and expiry details were included on all stocks of medicines; and that pharmaceutical
waste was promptly transferred to disposal containers, amounted to misconduct.
The Committee also found proved a conviction at the Leeds Crown Court of seven
counts of false accounting contrary to section 17(1)(a) of the Theft Act 1968
and six counts of obtaining a money transfer by deception contrary to section
15A of the Theft Act 1968. Under Section 11 of the Pharmacy Act 1954, the direction
to remove Mr Shabir’s name from the Register is not to take effect until
the expiration of a period of three months from the date on which notice of
removal was given or in a case where an appeal has been brought against the
direction, until the appeal is determined or withdrawn.
4. Following an inquiry into the case of Peter Howard Freeman (registration
number 86570) and P. H. Freeman Ltd (identification number 1003556) the committee
resolved to issue both Mr Freeman and P.H. Freeman Ltd with a reprimand. The
committee found proved the allegations that: signing and submitting to Leeds
West Primary Care Trust on or about 15 April 2005 a fitness-to-practise declaration
containing information which Mr Freeman knew to be false; signing and submitting
to South Leeds PCT on or about 17 April 2005 a fitness-to-practise declaration
containing information which Mr Freeman knew to be false; and failing to disclose
in a letter to Leeds West PCT (a) the company’s conviction on 12 January
1999, (b) Mr Freeman’s conviction on 12 January 1999 and (c) Mr Freeman’s
conviction on 19 February 2004, amounted to misconduct.
Fitness to Practise Committees Secretariat |
The
Pharmaceutical Journal